Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #FDA Approval #Quarterly Results #Novo Nordisk #Hoffmann-La Roche

Category: Healthcare & Pharmaceuticals

Clinical Trials Healthcare & Pharmaceuticals

Pembrolizumab, an immunotherapy medication, improves outcomes for patients with soft tissue sarcoma

  • By Journal Updates
  • 14 November 2024
pembrolizumab

A class of tumors known as soft tissue sarcoma of the extremities develops in the muscles, tendons, fat, blood vessels, or nerves of the arms and leg

Tagged Pembrolizumab
Weight-loss Drugs Research

New anti-obesity drugs reduces weight-loss surgery numbers

  • By Journal Updates
  • 30 October 2024
ozempic injection

In 2022–2023, the researchers found people diagnosed with obesity without diabetes using a nationwide sample of medical insurance claims data from over 17 million persons with private insurance.

Research Healthcare & Pharmaceuticals Neuroscience

Risk of Alzheimer’s can be reduced by popular diabetes and weight-loss drug

  • By Journal Updates
  • 26 October 2024
epilepsy brain

The active ingredient in the diabetes and weight-loss medications Wegovy and Ozempic is semaglutide, a glucagon-like peptide receptor (GLP-1R) molecule that reduces appetite and aids in blood sugar regulation in type 2 diabetes.

Tagged Alzheimer's, Diabetes, Weight-loss Drugs
Clinical Trials Cancer Regulatory Approval

FDA Approval After Promising Results for Reducing Breast Cancer in Clinical Trials

  • By Journal Updates
  • 21 October 2024
breakwater trial representation

Teri Boudreaux is thankful for the time she gets to spend with her family, whether it’s hiking, playing with her grandkids, travelling with her spouse, [Read More…]

Tagged Breast Cancer, FDA, FDA Approval
Healthcare & Pharmaceuticals News Vaccines

New mRNA vaccine against Clostridioides difficile caused infections

  • By Journal Updates
  • 19 October 2024
Clostridioides difficile structure

C. difficile vaccine protected against C. difficile first-time infections and relapsing infections in animal models by eliciting a strong immune response, facilitating the removal of pre-existing C. diff bacteria from the gut

Tagged mRNA Vaccine
Healthcare & Pharmaceuticals News

Environmental Bacteria Could Form Better Antibiotics

  • By Journal Updates
  • 16 August 2024
Caulobacter

Results showed that the deletion of a protein, OpgH, in a model bacterium, Caulobacter crescentus, sets off an event cascade that ultimately splits apart the protective, bubble-like cell envelope, eventually killing the cell.

Tagged Antibiotics, Bacteria
Healthcare & Pharmaceuticals News Research

Research promises a universal flu vaccine

  • By Editor's Desk
  • 22 July 2024
vaccine vial image

Six out of eleven nonhuman primates who received an inoculation against the 1918 flu virus, which was prevalent a century ago, reportedly withstood exposure to H5N1, one of the worst viruses now circulating in the globe. On the other hand, six uninfected monkeys in the control group that were infected with the H5N1 virus died from the illness.

Tagged Universal Flu Vaccine
Healthcare & Pharmaceuticals News Research

New antibody therapy to neutralize a wide variety of HIV-1 strains

  • By Editor's Desk
  • 19 July 2024
hiv antibody therapy

This new study offers a broadly useful technique to improve nanobodies’ performance. Artificially created antibody fragments, known as nanobodies, are around 10 times smaller than regular antibodies.

Tagged Antibody Therapy, HIV
Healthcare & Pharmaceuticals News Research

Advancement in research improves checkpoint inhibitor therapy for cancer

  • By Editor's Desk
  • 27 June 2024
gene expression regulation in cancer representation

Researchers at Scripps Research have recently discovered that when taken with checkpoint inhibitors, the immunosuppressive medication ruxolitinib, which is licenced, enhanced T-cell responses and increased the drugs’ ability to fight cancer.

Tagged Cancer, Cancer Therapy
Mental Health News

Activity in the gut microbiome and brain can influence resilient individuals

  • By Editor's Desk
  • 26 June 2024
gut microbiome and brain

This research appears to be the first to investigate the relationship between gut microbiota, brain function, and resilience.

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Roche Enspryng MOGAD Filing Wins FDA Priority Review as First Potential Treatment for Rare Neuroimmune Disease
Regulatory Healthcare & Pharmaceuticals News Rare Diseases

Roche Enspryng MOGAD Filing Wins FDA Priority Review as First Potential Treatment for Rare Neuroimmune Disease

10 September 202611 September 2026
Clinical Trials & Data Desk
Charles River Endosafe Cartridge Manufacturing Goes Fully Automated at Massachusetts Facility
CRDMO Business Healthcare & Pharmaceuticals News Technology

Charles River Endosafe Cartridge Manufacturing Goes Fully Automated at Massachusetts Facility

10 September 202610 September 2026
BiotechReality Business Intelligence Desk
Amgen: IMDELLTRA Imfinzi Combination Delivers Landmark Survival Gain in DeLLphi-305 Trial
Clinical Data Healthcare & Pharmaceuticals News Oncology

Amgen: IMDELLTRA Imfinzi Combination Delivers Landmark Survival Gain in DeLLphi-305 Trial

9 September 20269 September 2026
Clinical Trials & Data Desk
Semaglutide Childhood Obesity Trial Meets Primary Endpoint as Novo Nordisk’s STEP Young Study Shows 40.4% of Children No Longer Classified as Having Obesity
Clinical Data Anti-obesity Drugs Healthcare & Pharmaceuticals News Weight-loss Drugs

Semaglutide Childhood Obesity Trial Meets Primary Endpoint as Novo Nordisk’s STEP Young Study Shows 40.4% of Children No Longer Classified as Having Obesity

8 September 20268 September 2026
Clinical Trials & Data Desk
Novartis Pelacarsen Lp(a)HORIZON Trial Results: Phase III Study Misses Primary Cardiovascular Endpoint
Clinical Data Healthcare & Pharmaceuticals News

Novartis Pelacarsen Lp(a)HORIZON Trial Results: Phase III Study Misses Primary Cardiovascular Endpoint

7 September 20268 September 2026
Clinical Trials & Data Desk
IQVIA Predictive Clinical Development Cuts Trial Delays With AI-Powered Approach
Technology Clinical Trials CRO Healthcare & Pharmaceuticals News

IQVIA Predictive Clinical Development Cuts Trial Delays With AI-Powered Approach

6 September 20266 September 2026
BiotechReality Business Intelligence Desk
Advertisement
BiotechReality JobFinder

  • Senior Clinical Data Scientist – Novo Nordisk
    6 September 2026
  • Application Scientist Pharma and Biopharma – Thermo Fisher Scientific
    30 August 2026
  • Product Marketing Data Analyst – Pall (Danaher)
    23 August 2026
  • Financial Analyst, FP&A – Cytiva
    16 August 2026
  • Field Service Account Manager – Bausch+Ströbel
    15 August 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter